|
Serper, M R; Davidson, M; Harvey, P D (1994) Attentional predictors of clinical change during neuroleptic treatment in schizophrenia. Schizophr Res 13:65-71
|
|
Stern, R G; Kahn, R S; Davidson, M et al. (1994) Early response to clozapine in schizophrenia. Am J Psychiatry 151:1817-8
|
|
Davidson, M; Kahn, R S; Stern, R G et al. (1993) Treatment with clozapine and its effect on plasma homovanillic acid and norepinephrine concentrations in schizophrenia. Psychiatry Res 46:151-63
|
|
Stern, R G; Kahn, R S; Harvey, P D et al. (1993) Early response to haloperidol treatment in chronic schizophrenia. Schizophr Res 10:165-71
|
|
Kahn, R S; Davidson, M; Hirschowitz, J et al. (1992) Nocturnal growth hormone secretion in schizophrenic patients and healthy subjects. Psychiatry Res 41:155-61
|
|
Keefe, R S; Lobel, D S; Mohs, R C et al. (1991) Diagnostic issues in chronic schizophrenia: kraepelinian schizophrenia, undifferentiated schizophrenia, and state-independent negative symptoms. Schizophr Res 4:71-9
|
|
Harvey, P D; Davidson, M; Powchik, P et al. (1991) Time course and clinical predictors of treatment response in schizophrenia. Schizophr Res 5:161-6
|
|
Davis, K L; Kahn, R S; Ko, G et al. (1991) Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 148:1474-86
|
|
Davidson, M; Kahn, R S; Knott, P et al. (1991) Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations. Arch Gen Psychiatry 48:910-3
|
|
Harvey, P D; Putnam, K M; Davidson, M et al. (1991) Brief neuroleptic discontinuation and clinical symptoms in Kraepelinian and non-Kraepelinian chronic schizophrenic patients. Psychiatry Res 38:285-92
|
Showing the most recent 10 out of 17 publications
